| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |